» Articles » PMID: 32252359

Chronic Stress Contributes to Osteosarcopenic Adiposity Via Inflammation and Immune Modulation: The Case for More Precise Nutritional Investigation

Overview
Journal Nutrients
Date 2020 Apr 8
PMID 32252359
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic stress and low-grade chronic inflammation (LGCI) are key underlying factors formany diseases, including bone and body composition impairments. Objectives of this narrativereview were to examine the mechanisms by which chronic stress and LGCI may influenceosteosarcopenic adiposity (OSA) syndrome, originally named as ostoesarcopenic obesity (OSO).We also examined the crucial nutrients presumed to be affected by or cause of stress andinflammation and compared/contrasted them to those of our prehistoric ancestors. The evidenceshows that stress (particularly chronic) and its related inflammatory processes, contribute toosteoporosis, sarcopenia, and adiposity ultimately leading to OSA as a final and most derangedstate of body composition, commencing at the mesenchymal cell lineage disturbance. Thefoods/nutrients consumed by modern humans, as well as their altered lifestyle, also contribute tostress, LGCI and subsequently to OSA. The processes can also go in opposite direction when stressand inflammation impact nutritional status, particularly some micronutrients' levels. Whilenutritional management of body composition and LGCI have been studied, the nutrients (and theirquantities) most affected by stressors and those which may act toward the alleviation of stressfulstate, ultimately leading to better body composition outcomes, need to be elucidated.

Citing Articles

Chronic stress-mediated dysregulations in inflammatory, immune and oxidative circuitry impairs the therapeutic response of methotrexate in experimental autoimmune disease models.

Chaudhary R, Azam M, Dowand B, Singh A, Rehman M, Agarwal V Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39453502 DOI: 10.1007/s00210-024-03529-2.


Understanding the Consequences of Fatty Bone and Fatty Muscle: How the Osteosarcopenic Adiposity Phenotype Uncovers the Deterioration of Body Composition.

Hu K, Deya Edelen E, Zhuo W, Khan A, Orbegoso J, Greenfield L Metabolites. 2023; 13(10).

PMID: 37887382 PMC: 10608812. DOI: 10.3390/metabo13101056.


Chronic unpredictable mild stress promotes atherosclerosis adipose tissue dysfunction in ApoE mice.

Mao M, Deng Y, Wang L, Zhao G, Qi R, Gong H PeerJ. 2023; 11:e16029.

PMID: 37692113 PMC: 10484201. DOI: 10.7717/peerj.16029.


Nutrition and Physical Activity as Modulators of Osteosarcopenic Adiposity: A Scoping Review and Recommendations for Future Research.

Vucic V, Ristic-Medic D, Arsic A, Petrovic S, Paunovic M, Vasiljevic N Nutrients. 2023; 15(7).

PMID: 37049460 PMC: 10096523. DOI: 10.3390/nu15071619.


Cellular and Molecular Mechanisms Associating Obesity to Bone Loss.

Forte Y, Renovato-Martins M, Barja-Fidalgo C Cells. 2023; 12(4).

PMID: 36831188 PMC: 9954309. DOI: 10.3390/cells12040521.


References
1.
Eaton S, Konner M . Paleolithic nutrition. A consideration of its nature and current implications. N Engl J Med. 1985; 312(5):283-9. DOI: 10.1056/NEJM198501313120505. View

2.
Eaton S, Cordain L, Sparling P . Evolution, body composition, insulin receptor competition, and insulin resistance. Prev Med. 2009; 49(4):283-5. DOI: 10.1016/j.ypmed.2009.08.002. View

3.
Kelly O, Gilman J, Boschiero D, Ilich J . Osteosarcopenic Obesity: Current Knowledge, Revised Identification Criteria and Treatment Principles. Nutrients. 2019; 11(4). PMC: 6520721. DOI: 10.3390/nu11040747. View

4.
Raschke S, Eckel J . Adipo-myokines: two sides of the same coin--mediators of inflammation and mediators of exercise. Mediators Inflamm. 2013; 2013:320724. PMC: 3686148. DOI: 10.1155/2013/320724. View

5.
Hotamisligil G . Inflammation and metabolic disorders. Nature. 2006; 444(7121):860-7. DOI: 10.1038/nature05485. View